Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 73 | 2023 | 624 | 14.960 |
Why?
|
| Arthroplasty, Replacement, Hip | 48 | 2023 | 822 | 10.010 |
Why?
|
| Knee Prosthesis | 28 | 2023 | 223 | 8.610 |
Why?
|
| Knee Joint | 42 | 2022 | 754 | 6.240 |
Why?
|
| Hip Prosthesis | 26 | 2023 | 552 | 6.170 |
Why?
|
| Femur | 20 | 2020 | 400 | 4.570 |
Why?
|
| Surgery, Computer-Assisted | 16 | 2017 | 53 | 4.520 |
Why?
|
| Prosthesis Failure | 24 | 2023 | 539 | 3.560 |
Why?
|
| Prosthesis Design | 28 | 2023 | 503 | 3.250 |
Why?
|
| Osteoarthritis, Knee | 20 | 2019 | 363 | 3.200 |
Why?
|
| Tibia | 17 | 2019 | 257 | 3.020 |
Why?
|
| Middle Aged | 80 | 2021 | 9306 | 2.770 |
Why?
|
| Hip Joint | 17 | 2017 | 549 | 2.660 |
Why?
|
| Retrospective Studies | 55 | 2022 | 3612 | 2.570 |
Why?
|
| Bone Cements | 7 | 2023 | 91 | 2.560 |
Why?
|
| Reoperation | 25 | 2023 | 917 | 2.550 |
Why?
|
| Aged | 70 | 2021 | 9339 | 2.420 |
Why?
|
| Humans | 123 | 2023 | 28462 | 2.360 |
Why?
|
| Postoperative Period | 22 | 2020 | 331 | 2.200 |
Why?
|
| Female | 82 | 2022 | 15793 | 2.140 |
Why?
|
| Male | 81 | 2022 | 15367 | 2.130 |
Why?
|
| Pain, Postoperative | 11 | 2020 | 316 | 1.970 |
Why?
|
| Postoperative Complications | 15 | 2022 | 934 | 1.880 |
Why?
|
| Osteoarthritis, Hip | 5 | 2018 | 107 | 1.720 |
Why?
|
| Patient Satisfaction | 8 | 2019 | 329 | 1.700 |
Why?
|
| Metal-on-Metal Joint Prostheses | 5 | 2017 | 51 | 1.680 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 772 | 1.670 |
Why?
|
| Prospective Studies | 21 | 2020 | 1810 | 1.570 |
Why?
|
| Bone Malalignment | 7 | 2014 | 20 | 1.520 |
Why?
|
| Treatment Outcome | 31 | 2023 | 3619 | 1.520 |
Why?
|
| Acetabulum | 6 | 2016 | 235 | 1.510 |
Why?
|
| Anticoagulants | 4 | 2015 | 90 | 1.460 |
Why?
|
| Adult | 38 | 2019 | 8152 | 1.460 |
Why?
|
| Venous Thromboembolism | 3 | 2015 | 36 | 1.420 |
Why?
|
| Joint Diseases | 4 | 2016 | 113 | 1.370 |
Why?
|
| Radiography | 20 | 2017 | 651 | 1.310 |
Why?
|
| Range of Motion, Articular | 15 | 2017 | 725 | 1.290 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2017 | 1196 | 1.230 |
Why?
|
| Recovery of Function | 11 | 2016 | 300 | 1.210 |
Why?
|
| Noise | 3 | 2017 | 31 | 1.200 |
Why?
|
| Warfarin | 4 | 2015 | 26 | 1.190 |
Why?
|
| Bone Density | 3 | 2018 | 149 | 1.140 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2016 | 235 | 1.110 |
Why?
|
| Chromium | 3 | 2016 | 91 | 1.100 |
Why?
|
| Cobalt | 3 | 2016 | 113 | 1.070 |
Why?
|
| Metals | 4 | 2017 | 152 | 1.060 |
Why?
|
| Prosthesis-Related Infections | 5 | 2020 | 186 | 1.050 |
Why?
|
| Aspirin | 3 | 2015 | 84 | 1.020 |
Why?
|
| Foreign-Body Reaction | 2 | 2017 | 29 | 1.020 |
Why?
|
| Venous Thrombosis | 2 | 2015 | 46 | 0.920 |
Why?
|
| Osteolysis | 2 | 2017 | 144 | 0.910 |
Why?
|
| Titanium | 4 | 2020 | 183 | 0.870 |
Why?
|
| Arthritis | 4 | 2020 | 53 | 0.860 |
Why?
|
| Biomechanical Phenomena | 11 | 2017 | 676 | 0.820 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 4904 | 0.820 |
Why?
|
| Cholecalciferol | 1 | 2022 | 6 | 0.820 |
Why?
|
| Synovial Fluid | 2 | 2020 | 95 | 0.810 |
Why?
|
| Hip Dislocation | 6 | 2023 | 73 | 0.790 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2021 | 4 | 0.790 |
Why?
|
| Arthroplasty, Replacement | 4 | 2013 | 154 | 0.770 |
Why?
|
| Age Factors | 9 | 2018 | 793 | 0.760 |
Why?
|
| Accelerometry | 2 | 2012 | 88 | 0.750 |
Why?
|
| Surgical Wound | 2 | 2018 | 9 | 0.750 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 1216 | 0.740 |
Why?
|
| Surgical Wound Infection | 3 | 2021 | 88 | 0.730 |
Why?
|
| Registries | 2 | 2018 | 191 | 0.700 |
Why?
|
| Pain Measurement | 4 | 2016 | 473 | 0.690 |
Why?
|
| Specimen Handling | 1 | 2020 | 44 | 0.680 |
Why?
|
| Lower Extremity | 3 | 2015 | 40 | 0.670 |
Why?
|
| Periprosthetic Fractures | 1 | 2020 | 26 | 0.670 |
Why?
|
| Joint Dislocations | 3 | 2023 | 55 | 0.630 |
Why?
|
| Computer-Aided Design | 2 | 2016 | 15 | 0.630 |
Why?
|
| Equipment Failure Analysis | 4 | 2014 | 110 | 0.630 |
Why?
|
| Incidence | 9 | 2018 | 779 | 0.630 |
Why?
|
| Intermittent Pneumatic Compression Devices | 2 | 2015 | 7 | 0.600 |
Why?
|
| Acceleration | 3 | 2012 | 21 | 0.590 |
Why?
|
| Research Design | 3 | 2015 | 208 | 0.590 |
Why?
|
| Ankle Joint | 5 | 2016 | 44 | 0.570 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 992 | 0.560 |
Why?
|
| Genu Varum | 1 | 2017 | 4 | 0.560 |
Why?
|
| Weight-Bearing | 2 | 2014 | 171 | 0.550 |
Why?
|
| Risk Factors | 9 | 2022 | 2421 | 0.550 |
Why?
|
| Cadaver | 4 | 2012 | 389 | 0.550 |
Why?
|
| Risk Assessment | 3 | 2018 | 676 | 0.550 |
Why?
|
| Pelvic Bones | 1 | 2016 | 18 | 0.540 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2019 | 508 | 0.520 |
Why?
|
| Femur Neck | 1 | 2016 | 21 | 0.520 |
Why?
|
| Supine Position | 1 | 2016 | 21 | 0.520 |
Why?
|
| Prosthesis Fitting | 2 | 2013 | 21 | 0.520 |
Why?
|
| Posture | 4 | 2017 | 68 | 0.510 |
Why?
|
| Analgesics, Opioid | 6 | 2020 | 216 | 0.510 |
Why?
|
| Young Adult | 10 | 2019 | 2100 | 0.500 |
Why?
|
| Patient Discharge | 3 | 2019 | 162 | 0.500 |
Why?
|
| Hypersensitivity | 1 | 2016 | 48 | 0.500 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 312 | 0.470 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 18 | 0.470 |
Why?
|
| Osteoarthritis | 2 | 2016 | 331 | 0.440 |
Why?
|
| Patella | 1 | 2014 | 72 | 0.440 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 726 | 0.430 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 79 | 0.430 |
Why?
|
| Leg Length Inequality | 1 | 2013 | 9 | 0.420 |
Why?
|
| Fibrosis | 1 | 2013 | 30 | 0.420 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 66 | 0.410 |
Why?
|
| Missouri | 4 | 2016 | 27 | 0.410 |
Why?
|
| Computer Simulation | 2 | 2016 | 204 | 0.410 |
Why?
|
| Time Factors | 8 | 2019 | 1497 | 0.400 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 14 | 0.400 |
Why?
|
| Muscular Diseases | 1 | 2012 | 18 | 0.390 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 376 | 0.380 |
Why?
|
| Blood Transfusion | 4 | 2022 | 66 | 0.370 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 412 | 0.370 |
Why?
|
| United States | 9 | 2018 | 2185 | 0.370 |
Why?
|
| Viscosity | 4 | 2019 | 9 | 0.360 |
Why?
|
| Porosity | 2 | 2022 | 61 | 0.360 |
Why?
|
| Rotation | 4 | 2014 | 142 | 0.360 |
Why?
|
| Pain | 4 | 2019 | 406 | 0.350 |
Why?
|
| Osteoporosis | 1 | 2011 | 77 | 0.350 |
Why?
|
| Joint Prosthesis | 4 | 2019 | 89 | 0.330 |
Why?
|
| Patient Positioning | 4 | 2017 | 41 | 0.330 |
Why?
|
| Adolescent | 6 | 2019 | 2324 | 0.330 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 424 | 0.330 |
Why?
|
| Spinal Fusion | 1 | 2016 | 473 | 0.330 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 1868 | 0.320 |
Why?
|
| Rotator Cuff | 1 | 2012 | 297 | 0.320 |
Why?
|
| Length of Stay | 5 | 2019 | 328 | 0.310 |
Why?
|
| Body Mass Index | 4 | 2020 | 466 | 0.300 |
Why?
|
| Femur Head | 4 | 2023 | 71 | 0.300 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2018 | 11 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2019 | 263 | 0.290 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 146 | 0.290 |
Why?
|
| Joint Instability | 4 | 2019 | 397 | 0.280 |
Why?
|
| Corrosion | 3 | 2017 | 134 | 0.280 |
Why?
|
| Absorptiometry, Photon | 2 | 2018 | 82 | 0.280 |
Why?
|
| Arthroplasty, Replacement, Elbow | 2 | 2019 | 7 | 0.280 |
Why?
|
| Osteocytes | 2 | 2019 | 18 | 0.270 |
Why?
|
| Blood Loss, Surgical | 2 | 2020 | 59 | 0.270 |
Why?
|
| Polyethylene | 4 | 2019 | 132 | 0.270 |
Why?
|
| Hip Fractures | 2 | 2018 | 26 | 0.270 |
Why?
|
| Arthroscopy | 2 | 2014 | 1088 | 0.260 |
Why?
|
| Sex Factors | 3 | 2017 | 480 | 0.260 |
Why?
|
| Patient Readmission | 3 | 2018 | 133 | 0.260 |
Why?
|
| Pain Management | 4 | 2020 | 147 | 0.260 |
Why?
|
| Elbow Joint | 2 | 2019 | 125 | 0.250 |
Why?
|
| Cytokines | 2 | 2019 | 233 | 0.240 |
Why?
|
| Hemorrhage | 2 | 2015 | 81 | 0.240 |
Why?
|
| Hand | 2 | 2018 | 40 | 0.240 |
Why?
|
| Awards and Prizes | 2 | 2016 | 22 | 0.230 |
Why?
|
| Stress, Mechanical | 3 | 2014 | 170 | 0.220 |
Why?
|
| Comorbidity | 2 | 2022 | 502 | 0.220 |
Why?
|
| Therapeutic Irrigation | 2 | 2020 | 56 | 0.210 |
Why?
|
| Double-Blind Method | 2 | 2022 | 424 | 0.210 |
Why?
|
| Cohort Studies | 4 | 2020 | 1948 | 0.210 |
Why?
|
| Urinary Retention | 1 | 2022 | 11 | 0.210 |
Why?
|
| Gait | 2 | 2017 | 411 | 0.210 |
Why?
|
| Patient Selection | 2 | 2014 | 209 | 0.200 |
Why?
|
| Time and Motion Studies | 1 | 2022 | 18 | 0.200 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 33 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2022 | 67 | 0.200 |
Why?
|
| Vitamin D | 1 | 2022 | 41 | 0.200 |
Why?
|
| Algorithms | 3 | 2019 | 378 | 0.200 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 59 | 0.190 |
Why?
|
| Equipment Design | 2 | 2012 | 154 | 0.190 |
Why?
|
| Cementation | 1 | 2021 | 33 | 0.190 |
Why?
|
| Postural Balance | 1 | 2022 | 122 | 0.180 |
Why?
|
| Surface Properties | 2 | 2019 | 139 | 0.180 |
Why?
|
| Orthopedics | 2 | 2013 | 113 | 0.180 |
Why?
|
| Refuse Disposal | 1 | 2020 | 2 | 0.180 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 17 | 0.180 |
Why?
|
| Tranexamic Acid | 1 | 2020 | 17 | 0.170 |
Why?
|
| Leukocyte Count | 1 | 2020 | 66 | 0.170 |
Why?
|
| Prescriptions | 1 | 2020 | 18 | 0.170 |
Why?
|
| Acetaminophen | 1 | 2020 | 24 | 0.170 |
Why?
|
| Los Angeles | 2 | 2017 | 10 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2019 | 20 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 67 | 0.170 |
Why?
|
| Arthroplasty | 2 | 2018 | 150 | 0.170 |
Why?
|
| Neutrophils | 1 | 2020 | 106 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 179 | 0.160 |
Why?
|
| Pain Perception | 1 | 2019 | 4 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2019 | 135 | 0.160 |
Why?
|
| Oxycodone | 1 | 2019 | 4 | 0.160 |
Why?
|
| Pelvis | 2 | 2016 | 32 | 0.160 |
Why?
|
| Wound Healing | 2 | 2018 | 160 | 0.160 |
Why?
|
| Survivorship | 1 | 2019 | 20 | 0.160 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 161 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 24 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2019 | 32 | 0.160 |
Why?
|
| Apoptosis | 1 | 2019 | 203 | 0.160 |
Why?
|
| alpha-Defensins | 1 | 2018 | 3 | 0.150 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 75 | 0.150 |
Why?
|
| Ceramics | 2 | 2015 | 22 | 0.150 |
Why?
|
| Morphine | 1 | 2019 | 61 | 0.150 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 7 | 0.150 |
Why?
|
| Logistic Models | 2 | 2016 | 397 | 0.150 |
Why?
|
| Surgeons | 2 | 2019 | 89 | 0.150 |
Why?
|
| Bone Remodeling | 1 | 2018 | 49 | 0.150 |
Why?
|
| Drainage | 1 | 2018 | 49 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2018 | 358 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 122 | 0.140 |
Why?
|
| Arthritis, Infectious | 1 | 2018 | 53 | 0.140 |
Why?
|
| Preoperative Period | 2 | 2020 | 81 | 0.140 |
Why?
|
| Knee | 1 | 2017 | 46 | 0.140 |
Why?
|
| Spine | 1 | 2018 | 111 | 0.140 |
Why?
|
| Motion | 1 | 2016 | 22 | 0.140 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.140 |
Why?
|
| Sacrum | 1 | 2016 | 24 | 0.130 |
Why?
|
| Fascia Lata | 1 | 2016 | 14 | 0.130 |
Why?
|
| Ions | 1 | 2016 | 53 | 0.130 |
Why?
|
| Thigh | 1 | 2016 | 33 | 0.130 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 41 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 2016 | 56 | 0.130 |
Why?
|
| Auditory Perception | 1 | 2016 | 43 | 0.130 |
Why?
|
| Rats | 2 | 2019 | 678 | 0.130 |
Why?
|
| Stockings, Compression | 1 | 2015 | 2 | 0.130 |
Why?
|
| Midwestern United States | 1 | 2016 | 63 | 0.130 |
Why?
|
| Internal Fixators | 1 | 2016 | 39 | 0.130 |
Why?
|
| Tennessee | 1 | 2015 | 9 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2014 | 125 | 0.120 |
Why?
|
| Great Lakes Region | 1 | 2015 | 1 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 334 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 28 | 0.120 |
Why?
|
| Regional Health Planning | 1 | 2014 | 4 | 0.120 |
Why?
|
| Joint Capsule | 2 | 2012 | 57 | 0.120 |
Why?
|
| Alloys | 1 | 2015 | 99 | 0.120 |
Why?
|
| Chemoprevention | 1 | 2014 | 4 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 64 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 628 | 0.120 |
Why?
|
| Drug Monitoring | 1 | 2014 | 17 | 0.120 |
Why?
|
| Patients | 1 | 2015 | 34 | 0.120 |
Why?
|
| Software | 1 | 2014 | 67 | 0.120 |
Why?
|
| Arthritis, Juvenile | 1 | 2014 | 7 | 0.120 |
Why?
|
| Knee Dislocation | 1 | 2014 | 4 | 0.120 |
Why?
|
| Perception | 1 | 2015 | 76 | 0.120 |
Why?
|
| Femoral Nerve | 1 | 2014 | 9 | 0.110 |
Why?
|
| Shoulder Joint | 2 | 2012 | 648 | 0.110 |
Why?
|
| Amides | 1 | 2014 | 16 | 0.110 |
Why?
|
| Survival Rate | 1 | 2015 | 356 | 0.110 |
Why?
|
| Sexual Behavior | 1 | 2014 | 57 | 0.110 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2014 | 6 | 0.110 |
Why?
|
| Obesity | 1 | 2017 | 322 | 0.110 |
Why?
|
| Analgesia, Epidural | 1 | 2014 | 54 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2016 | 293 | 0.110 |
Why?
|
| Patellar Ligament | 1 | 2014 | 42 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 188 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2013 | 53 | 0.110 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 81 | 0.110 |
Why?
|
| Connective Tissue | 1 | 2013 | 23 | 0.110 |
Why?
|
| Nerve Block | 1 | 2014 | 67 | 0.110 |
Why?
|
| Pressure | 1 | 2013 | 64 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2014 | 600 | 0.100 |
Why?
|
| Leg | 1 | 2013 | 53 | 0.100 |
Why?
|
| Femoral Neck Fractures | 1 | 2012 | 10 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 494 | 0.100 |
Why?
|
| Pregnancy | 1 | 2013 | 340 | 0.100 |
Why?
|
| Foreign-Body Migration | 1 | 2012 | 19 | 0.100 |
Why?
|
| Hip | 1 | 2013 | 65 | 0.100 |
Why?
|
| Vasculitis | 1 | 2012 | 29 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 97 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2013 | 152 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 339 | 0.100 |
Why?
|
| Chromium Alloys | 1 | 2012 | 49 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2012 | 113 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2014 | 241 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2012 | 63 | 0.100 |
Why?
|
| Hemiarthroplasty | 1 | 2012 | 35 | 0.100 |
Why?
|
| Arthritis, Psoriatic | 1 | 2012 | 14 | 0.100 |
Why?
|
| Computers, Handheld | 1 | 2011 | 12 | 0.100 |
Why?
|
| Intraoperative Period | 1 | 2011 | 27 | 0.100 |
Why?
|
| Patellar Dislocation | 1 | 2012 | 23 | 0.100 |
Why?
|
| Quality of Life | 1 | 2017 | 660 | 0.100 |
Why?
|
| External Fixators | 1 | 2011 | 11 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 276 | 0.100 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 32 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 476 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2011 | 60 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 228 | 0.090 |
Why?
|
| Arthralgia | 1 | 2012 | 125 | 0.090 |
Why?
|
| Shoulder Injuries | 1 | 2012 | 147 | 0.090 |
Why?
|
| Movement | 1 | 2011 | 117 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2013 | 448 | 0.090 |
Why?
|
| Athletic Injuries | 1 | 2012 | 175 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 939 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 133 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 382 | 0.090 |
Why?
|
| Animals | 2 | 2019 | 3798 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 40 | 0.080 |
Why?
|
| Rotator Cuff Injuries | 1 | 2012 | 316 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2011 | 217 | 0.070 |
Why?
|
| Risk | 2 | 2019 | 208 | 0.070 |
Why?
|
| Elective Surgical Procedures | 2 | 2019 | 39 | 0.070 |
Why?
|
| Early Ambulation | 2 | 2019 | 17 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 274 | 0.070 |
Why?
|
| Medicare | 2 | 2015 | 121 | 0.060 |
Why?
|
| Urinary Catheters | 1 | 2022 | 4 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 7 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 17 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 520 | 0.050 |
Why?
|
| Silver | 1 | 2021 | 4 | 0.050 |
Why?
|
| Bandages | 1 | 2021 | 7 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 166 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 43 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 111 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 48 | 0.040 |
Why?
|
| Bone-Implant Interface | 1 | 2019 | 7 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 97 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 88 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 111 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2019 | 85 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 75 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 364 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2019 | 303 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 145 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 267 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 81 | 0.040 |
Why?
|
| Colitis | 1 | 2017 | 37 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 149 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 179 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 27 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 68 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 64 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 612 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 161 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 34 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2015 | 29 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 601 | 0.030 |
Why?
|
| Medicaid | 1 | 2015 | 38 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 46 | 0.030 |
Why?
|
| Spain | 1 | 2014 | 9 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 5 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2014 | 27 | 0.030 |
Why?
|
| Zirconium | 1 | 2014 | 6 | 0.030 |
Why?
|
| Aluminum Oxide | 1 | 2014 | 7 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 22 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 158 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 9 | 0.030 |
Why?
|
| New York City | 1 | 2014 | 15 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 136 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 104 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 92 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 156 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2015 | 80 | 0.030 |
Why?
|
| Device Removal | 1 | 2014 | 92 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 311 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 398 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 95 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 255 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 186 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2014 | 113 | 0.030 |
Why?
|
| Fingers | 1 | 2012 | 11 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 2012 | 7 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 80 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 320 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2012 | 86 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 192 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 199 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 328 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 91 | 0.020 |
Why?
|
| Polyethylenes | 1 | 2009 | 39 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 139 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1423 | 0.020 |
Why?
|